Editorial Board

Journal of ImmunoTherapy of Cancer Editorial Board members have agreed and adhere to the BMJ Editor Roles and Responsibilities guidelines; including our Editor policy on competing interests.

Editor-in-Chief

Pedro Romero, MD
University of Lausanne, Switzerland
Declaration of Interests

Basic Tumor Immunology

Section Editor

Cornelis J. M. Melief, MD, PhD
Leiden University Medical Center, the Netherlands

Deputy Editor

Sjoerd H. van der Burg, PhD
Leiden University Medical Center, the Netherlands

Associate Editors

Scott I. Abrams, PhD
Roswell Park Cancer Institute, United States

Timothy NJ Bullock, PhD
University of Virginia, United States

Gennaro Ciliberto, MD
IRCCS Istituto Nazionale Tumori Regina Elena, Italy

Madhav Dhodapkar, MD
Winship Cancer Institute at Emory University, United States

Khashayarsha Khazaie, PhD, DSc
Mayo Clinic College of Medicine, United States

Michelle Krogsgaard, PhD
New York University School of Medicine, United States

Case Reports

Section Editor

Alfred Zippelius, MD
University Hospital Basel, Switzerland

Deputy Editor

Matthew D. Hellmann, MD
Memorial Sloan Kettering Cancer Center, United States

Associate Editors

Jack D. Bui, MD, PhD
University of California San Diego, United States

Richard D. Carvajal, MD
Columbia University Irving Medical Center, United States

Sebastian Kobold, MD
Klinikum der Universität München, Germany

Heinz Laubli, MD, PhD
University Hospital Basel, Switzerland

Steven H. Lin, MD, PhD
University of Texas MD Anderson Cancer Center, United States

Michael von Bergwelt-Baildon, MD, PhD
Klinikum der Universität München, Germany

Geoffrey R. Weiss, MD
University of Virginia, United States

Clinical/Translational Cancer Immunotherapy

Section Editors

James L. Gulley, MD, PhD, FACP
National Cancer Institute, National Institutes of Health, United States

Douglas G. McNeel, MD, PhD
University of Wisconsin Carbone Cancer Center, United States

Deputy Editor

Claudia Palena, PhD
National Cancer Institute, National Institutes of Health, United States

Associate Editors

Paulo Antonio Ascierto, MD
Istituto Nazional Tumori-Fondazione ‘G.Pascale’, Italy

Christian S. Hinrichs, MD
National Cancer Institute, National Institutes of Health, United States

Pawel Kalinski, MD, PhD
Roswell Park Cancer Institute, United States

Dung Le, MD
Johns Hopkins University, United States

Ravi A. Madan, MD
National Cancer Institute, National Institutes of Health, United States

Anna C. Pavlick, DO, MBA
New York University Cancer Institute, United States

Jeffrey S. Weber, MD, PhD
New York University Langone Medical Center, United States

Yi-Long Wu, MD
Chinese Society of Clinical Oncology, China

Cassian Yee, MD
University of Texas MD Anderson Cancer Center, United States

Clinical Trials Monitor

Section Editor

Leisha A. Emens, MD, PhD
UPMC Hillman Cancer Center, United States

Associate Editors

Tai-Tsang Chen, PhD
Columbia University; Bristol-Myers Squibb, United States

Jolanda de Vries, PhD
Radboud University Nijmegen, the Netherlands

Silvia Formenti, MD
Weill Cornell Medical College, United States

Larry W. Kwak, MD, PhD
City of Hope, United States

Sherene Loi, MD, PhD
Peter MacCallum Cancer Centre, Australia

Kunle Odunsi, MD, PhD
Roswell Park Cancer Institute, United States

Michael A. Postow, MD
Memorial Sloan-Kettering Cancer Center, United States

Hiroshi Shiku, MD
Mie University Graduate School of Medicine, Japan

Daniel E. Speiser, MD
Ludwig Institute for Cancer Research, Switzerland

Louis M. Weiner, MD
Georgetown-Lombardi Comprehensive Cancer Center, United States

Commentary/Editorials

Section Editor

Christian M. Capitini, MD
University of Wisconsin, Madison, United States

Associate Editors

Ana Carrizosa Anderson, MD
Harvard University, United States

Wolf Hervé Fridman, MD, PhD
Cordeliers Research Center, Paris, France

Bryon D. Johnson, PhD
Medical College of Wisconsin, United States

William J. Murphy, PhD
University of California, Davis, United States

Gabriel Rabinovich, PhD
Instituto de Biologia y Medicina Experimental (IByME), Argentina

William L. Redmond, PhD
Earle A. Chiles Research Institute, United States

Guidelines and Consensus Statements

Section Editor

Robert L. Ferris, MD, PhD
University of Pittsburgh Cancer Institute, United States

Associate Editors

Michael B. Atkins, MD
Georgetown-Lombardi Comprehensive Cancer Center, United States

Michael Platten, MD
Ruprecht-Karls University Heidelberg, Germany

Immune Cell Therapies and Immune Cell Engineering

Section Editor

Marcela V. Maus, MD, PhD
Massachusetts General Hospital, United States

Associate Editors

Michael R. Bishop, MD
University of Chicago, United States

Aude Chapuis, MD
Fred Hutchinson Cancer Research Center, United States

Yvonne Y. Chen, PhD
University of California, Los Angeles, United States

Marco L. Davila, MD, PhD
H. Lee Moffitt Cancer Center, United States

Gerald Linette, MD, PhD
University of Pennsylvania, United States

Marco Ruella, MD
University of Pennsylvania, United States

Lillian Seu, PhD
Allogene Therapeutics, United States

Eric L. Smith, MD, PhD
Memorial Sloan Kettering Cancer Center, United States

Cameron J. Turtle, MBBS, PhD, FRACP
Fred Hutchinson Cancer Research Center, United States

Immunotherapy Biomarkers

Section Editor

Ignacio Melero, MD, PhD
University of Navarra, Spain

Deputy Editor

Kurt Schalper, MD, PhD
Yale School of Medicine, United States

Associate Editors

Luigi Buonaguro, MD
National Cancer Institute ‘Pascale’, Italy

Lisa H. Butterfield, PhD
Parker Institute for Cancer Immunotherapy, United States

John C. Castle, PhD
Agenus, Germany

Alessandra Cesano, MD, PhD
ESSA Pharma Inc., United States

Priti S. Hegde, PhD
Foundation Medicine, United States

Michael D. Kalos, PhD
Arsenal Biosciences, United States

Rejean Lapointe, PhD
Universite De Montreal, University Hospital (CRCHUM), Canada

Christian H. Ottensmeier, MD, PhD, FRCP
University of Southampton, United Kingdom

Graham P. Pawelec, PhD
University of Tuebingen, Germany

Licia Rivoltini, MD
Fondazione IRCCS Istituto Nazionale Tumori, Italy

Barbara Seliger, MD, PhD
Martin Luther University Halle-Wittenberg, Germany

Craig L. Slingluff Jr., MD
University of Virginia, United States

Alexandra Snyder Charen, MD
Merck & Co., United States

Jinada Yuan, MD, PhD
Merck & Co., United States

Oncolytic and Local Immunotherapy

Section Editor

Howard L. Kaufman, MD, FACS
Massachusetts General Hospital, United States

Associate Editors

John C. Bell, PhD
Ottawa Hospital Research Institute, Canada

Kevin Harrington, PhD, FRCP, FRCR
The Institute of Cancer Research, United Kingdom

Samuel Rabkin, PhD
Massachusetts General Hospital, United States

Stephen J. Russell, MD, PhD
Mayo Clinic College of Medicine, United States

Ann W. Silk, MD, MS
Dana-Farber Cancer Institute, United States

Reviews

Section Editors

Sandra Demaria, MD, FACS
Weill Cornell Medical College, United States

Lawrence Fong, MD
University of California, San Francisco, United States

Associate Editors

Michael B. Atkins, MD
Georgetown-Lombardi Comprehensive Cancer Center, United States

Ira Mellman, PhD
Genentech, United States

James J. Mule, PhD
H. Lee Moffitt Cancer Center & Research Institute, United States

Social Media and Consulting Editors

Social Media Editor

Jason Luke, MD
University of Pittsburgh Medical Center, United States

Consulting Editor

Thomas F. Gajewski, MD, PhD
University of Chicago, United States